Danielle Schlosser

SVP, Clinical Innovation, Compass Pathways Ltd

I am the Senior VP of Clinical Innovation at COMPASS Pathways, a mental health company dedicated to accelerating patient access to evidence-based innovation in mental health. In prior roles, I was responsible for developing the vision and overall strategy for the Behavioral Health portfolio at Verily Life Sciences, an Alphabet company. Prior to joining Verily, I was an Assistant Professor of Psychiatry at the University of California, San Francisco Weill Institute for Neurosciences and the Director of an NIMH-funded translational neuroscience lab. My lab developed digital therapeutics for individuals with serious mental illness. My work has been featured in several media outlets including, CNN, Technical Times, Fortune Magazine, and the Pacific Standard. I serve as Board Chair of OneFifteen, Member of the World Economic Forum Global Futures Council on Mental Health and Technology; USC Schaeffer Center as a Scientific Advisor, and remain a faculty mentor for several fellowship programs at UCSF, including the distinguished ACGME Clinical Informatics Fellowship Program; the Clifford Attkinson Clinical Services Research Training Program; and the Psychology and Medicine: An Integrative Research Approach fellowship.

メルマガの登録

グローバル・アジェンダのウィークリー・アップデート

© 2021 World Economic Forum

プライバシーポリシーと利用規約